Leveraging rapid sterility testing to advance cell therapy production

Cell & Gene Therapy Insights 2024; 1(4), 609

DOI: 18609/cgti.2024.073

Published: 3 June
Maya Dubey

Watch the video or view the poster to learn about:

  • Detecting specific bacterial and fungal species which are commonly associated with cell therapy product contamination
  • Leveraging the SteriSEQ Rapid Sterility Testing Kit within a cell therapy workflow
  • How the new system can deliver sensitivity, speed, efficiency, and accuracy

Maya Dubey is a Scientific Content Manager within the Pharma Analytics group at Thermo Fisher Scientific. She develops technical materials for both print and digital platforms. Prior to this role, Maya has gained extensive experience in the life science industry, holding various marketing positions as well as working as a research scientist specializing in cell and tissue culture. Maya holds a PhD in Biomedical Engineering and Biotechnology from the University of Massachusetts, where her doctoral dissertation focused on the impact of various proteins on neuronal growth and stability.